Amova Asset Management Americas Inc. Boosts Stake in Schrodinger, Inc. $SDGR

Amova Asset Management Americas Inc. increased its holdings in shares of Schrodinger, Inc. (NASDAQ:SDGR) by 13.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,190,837 shares of the company’s stock after acquiring an additional 371,167 shares during the quarter. Amova Asset Management Americas Inc.’s holdings in Schrodinger were worth $36,248,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of SDGR. EverSource Wealth Advisors LLC raised its holdings in Schrodinger by 722.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock valued at $25,000 after acquiring an additional 1,207 shares during the last quarter. Los Angeles Capital Management LLC acquired a new position in shares of Schrodinger during the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. grew its position in shares of Schrodinger by 5,025.8% in the fourth quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock valued at $28,000 after purchasing an additional 1,558 shares in the last quarter. State of Wyoming purchased a new stake in shares of Schrodinger in the second quarter valued at approximately $39,000. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in shares of Schrodinger in the fourth quarter valued at approximately $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrodinger Stock Performance

Shares of Schrodinger stock opened at $15.00 on Tuesday. The stock has a 50 day moving average of $14.93 and a 200 day moving average of $13.94. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -10.64 and a beta of 1.62. Schrodinger, Inc. has a fifty-two week low of $10.94 and a fifty-two week high of $23.75.

Schrodinger (NASDAQ:SDGR) last posted its earnings results on Tuesday, May 5th. The company reported ($0.81) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.25). Schrodinger had a negative net margin of 40.61% and a negative return on equity of 30.85%. The business had revenue of $58.59 million during the quarter, compared to analysts’ expectations of $47.57 million. During the same quarter in the prior year, the firm earned ($0.82) EPS. Schrodinger’s revenue for the quarter was down 1.6% compared to the same quarter last year. Analysts forecast that Schrodinger, Inc. will post -1.89 EPS for the current year.

Analyst Upgrades and Downgrades

SDGR has been the topic of a number of recent research reports. Wall Street Zen lowered Schrodinger from a “hold” rating to a “strong sell” rating in a research note on Saturday, May 9th. Morgan Stanley cut their target price on Schrodinger from $19.00 to $17.00 and set an “equal weight” rating for the company in a research note on Thursday, May 14th. KeyCorp reduced their price target on Schrodinger from $25.00 to $20.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Schrodinger in a research report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.25.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.